Drug
AV 412
AV 412: highest development phase Phase 1, developed by Aveo Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Aveo Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| AV-412 NCT00551850 | Phase 1 | Advanced Cancer |
Latest
No recent events.
Follow AV 412 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.